Company Information

Market
HKEX Main Board
Listing Date
2015-07-15
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG3961J1022

Industry

Innovative Drugs & Biologics 2.03%
124 stocks in this industry
Down 91 Up 17
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.11B52/112
Net Profit (Last FY)295.40M36/125
ROE (Last FY)18.25%14/117

Change is the 2026-11-13 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
ZENG Yong Executive Director
HUANG Jianping Executive Director
ZENG Kexiong Executive Director
HE Jinqiang Executive Director
JIANG Peizhen Non-Executive Director
LI Hua Independent Non-Executive Director
ZHU Jierong Independent Non-Executive Director
CHENG Yiqun Independent Non-Executive Director
QIN Jiesheng Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2024-06-05.

About this page

This page shows GOLDEN THROAT (06896) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect